The future of insulin pumps is clearly heading in toward tubeless, more autonomous, and longer-lasting. Companies are chasing designs that are smaller and easier to live with while extending wear times and reducing waste in the process.

Tandem’s upcoming Tubeless Mobi and Sigi patch pumps are among the most anticipated releases. Both aim to deliver the same trusted algorithms users already know, but in a more flexible wearable form. Beta Bionics is developing a reusable patch pump dubbed “mint” that cuts down on disposable parts, while Medtronic is preparing its first tubeless pump featuring a 7-day wear time and 300-unit reservoir. Meanwhile, Omnipod, the original tubeless pioneer, is expected to be working on its next version with a smarter algorithm and lower glucose targets to keep pace with this fast-moving field.

On the algorithm side, companies are moving closer to fully automated insulin delivery systems that could one day handle everything without user input. Still, accuracy and connectivity of continuous glucose monitors (CGMs) remain the key challenges to achieving a truly hands-off experience.

We break all of this down in our latest podcast with Endo and tech-entusiast, Dr. David Ahn, where we get into about the growing competition in tubeless systems, the future of AID algorithms, and what it will take to reach a fully automated pump experience. You can listen to the full conversation above or watch the video below to hear the full discussion in more detail.

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a physician before making changes to your healthcare.